María José Alonso Fernandez (born 22 December 1958) is a full professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela. The laboratory she leads is specialized in Pharmaceutical Nanotechnology and Nanomedicine, and her research is oriented to the development of nanostructures for targeted delivery of drugs and vaccines. Her discoveries have led to significant clinical advances in the development of potential new treatments for cancer, ocular diseases, skin diseases, diabetes, obesity and other autoimmune pathologies, as well as new vaccines.